Safety and quality concerns of medications are increasingly seeing healthcare providers opting to bring drug compounding under their own control.
Protak work with Hospitals during the design, development and delivery of pharmacy compounding systems for the preparation of oncology drugs including chemotherapy and biologicals and hospital isolators to handle cytotoxic products and hazardous ingredients.
Athena™, our bespoke software is used alongside Enzyme Indicators to deliver advanced reporting capability, enhanced audit and review features along with data archive facilities during validation cycles and the delivery of “challenge area” design specific reports that can be analysed against the facility design specification during handover testing and shared with your clients to inform future design modifications.
Read about the advantages and benefits of using our Enzyme Indicators for your H₂O₂ bio-decontamination validation processes.
Biological Indicators vs Enzyme Indicators at a glance.
Presentations, white papers, webinars, shared articles, project summaries and product analysis.